Colorectal tubulovillous adenomas identified on fluoro-2-deoxy-D -glucose positron emission tomography/computed tomography scans

Colorectal Disease

Volumn 10, Issue 4, 2008, Pages 386-389

  Hemandas, A K ^a   Robson, N K ^a   Hickish, T ^a   Talbot, R W ^a  

^a NONE   (United Kingdom)

Author keywords

Adenoma; Colorectal; Incidental; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ANUS CANCER; ARTICLE; CANCER STAGING; COLORECTAL ADENOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG UPTAKE; ESOPHAGUS CANCER; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; INCIDENTAL FINDING; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TONGUE CANCER; VILLOUS ADENOMA;

ADENOMA, VILLOUS; ADENOMATOUS POLYPS; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; GASTROINTESTINAL NEOPLASMS; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENTAL FINDINGS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 42149159430     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2007.01261.x     Document Type: Article

References (21)

1. Gutman F, Alberini JL, Wartski M et. al. Incidental colonic focal lesions detected by FDG PET/CT. Am J Roentgenol 2005; 185: 495-500.
2. Israel O, Yefremov N, Bar-Shalom R et. al. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: Incidence, localization patterns, and clinical significance. J Nucl Med 2005; 46: 758-62.
3. Chen YK, Kao CH, Liao AC, Shen YY, Su CT. Colorectal cancer screening in asymptomatic adults: The role of FDG PET scan. Anticancer Res 2003; 23: 4357-61.
4. Arslan N, Dehdashti F, Siegel BA. FDG uptake in colonic villous adenomas. Ann Nucl Med 2005; 19: 331-4.
5. Drenth JP, Nagengast FM, Oyen WJ. Evaluation of (pre-)malignant colonic abnormalities: Endoscopic validation of FDG-PET findings. Eur J Nucl Med 2001; 28: 1766-9.
6. Yasuda S, Fujii H, Nakahara T, Nishiumi N, Takahashi W, Ide M, Shohtsu A. 18 F-FDG PET detection of colonic adenomas. J Nucl Med 2001; 42: 989-92.
7. van Kouwen MC, Nagengast FM, Jansen JB, Oyen WJ, Drenth JP. 2-(18 F)-fluoro-2-deoxy- d -glucose positron emission tomography detects clinical relevant adenomas of the colon: A prospective study. J Clin Oncol 2005; 23: 3713-7.
8. Friedland S, Soetikno R, Carlisle M, Taur A, Kaltenbach T, Segall G. 18-Fluorodeoxyglucose positron emission tomography has limited sensitivity for colonic adenoma and early stage colon cancer. Gastrointest Endosc 2005; 61: 395-400.
9. Rini JN, Leonidas JC, Tomas MB, Palestro CJ. 18 F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma. J Nucl Med 2003; 44: 1072-4.
10. Moog F, Bangerter M, Diederichs CG et. al. Extranodal malignant lymphoma: Detection with FDG PET versus CT. Radiology 1998; 206: 475-81.
11. Steinert HC, Hauser M, Allemann F et. al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997; 202: 441-6.
12. Aide N, Cappele O, Bottet P et. al. Efficiency of [(18)F]FDG PET in characterising renal cancer and detecting distant metastases: A comparison with CT. Eur J Nucl Med Mol Imaging 2003; 30: 1236-45.
13. De Wever W, Ceyssens S, Mortelmans L et. al. Additional value of PET-CT in the staging of lung cancer: Comparison with CT alone, PET alone and visual correlation of PET and CT. Eur Radiol 2007; 17: 23-32.
14. Raanani P, Sasha Y, Perry C et. al. Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Ann Oncol 2006; 17: 117-22.
15. Cho D, Kocher O, Parker JA, Halmos B. Multiple positron-emission tomography false positives in a patient with malignant melanoma. Clin Oncol 2006; 18: 87-88.
16. Schneider BJ, Avram AM, Shulkin BL, Kalemkerian GP. False-positive findings with positron emission tomography in the staging of non-small-cell lung cancer. Clin Adv Hematol Oncol 2005; 3: 571-3.
17. Engel H, Steinert H, Buck A et. al. Whole-body PET: Physiological and artifactual fluorodeoxyglucose accumulation. J Nucl Med 1996; 37: 441-6.
18. Kim S, Chung JK, Kim BT et. al. Relationship between gastrointestinal F-18 fluorodeoxyglucose accumulation and gastrointestinal symptoms in whole-body PET. Clin Positron Imaging 1999; 2: 273-9.
19. Tatlidil R, Jadvar H, Bading JR, Conti PS. Incidental colonic fluorodeoxyglucose uptake: Correlation with colonoscopic and histopathologic findings. Radiology 2002; 224: 783-7.
20. Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 2005; 46: 752-7.
21. Winterton R. 11th October 2005. More Money for New Scanning Technology http://www.gnn.gov.uk/content/detail.asp?ReleaseID=172852&NewsAreaID= 2&NavigatedFromSearch=True